Crossmark

Accurate prediction of disease-risk factors from volumetric medical scans by a deep vision model pre-trained with 2D scans

Crossref DOI link: https://doi.org/10.1038/s41551-024-01257-9

Published Online: 2024-10-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Avram, Oren https://orcid.org/0000-0003-1984-2139
Durmus, Berkin https://orcid.org/0000-0002-8137-4439
Rakocz, Nadav https://orcid.org/0000-0001-5437-9691
Corradetti, Giulia

An, Ulzee https://orcid.org/0000-0001-8066-7291
Nittala, Muneeswar G.

Terway, Prerit

Rudas, Akos https://orcid.org/0000-0003-4346-8239
Chen, Zeyuan Johnson

Wakatsuki, Yu

Hirabayashi, Kazutaka

Velaga, Swetha

Tiosano, Liran

Corvi, Federico https://orcid.org/0000-0002-2661-5500
Verma, Aditya

Karamat, Ayesha

Lindenberg, Sophiana

Oncel, Deniz

Almidani, Louay

Hull, Victoria

Fasih-Ahmad, Sohaib

Esmaeilkhanian, Houri

Cannesson, Maxime

Wykoff, Charles C. https://orcid.org/0000-0001-7756-5091
Rahmani, Elior

Arnold, Corey W.

Zhou, Bolei

Zaitlen, Noah

Gronau, Ilan

Sankararaman, Sriram

Chiang, Jeffrey N. https://orcid.org/0000-0002-6843-1355
Sadda, Srinivas R. https://orcid.org/0000-0002-4939-3306
Halperin, Eran https://orcid.org/0000-0002-2373-3691
License Information

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-10-01
More Information

Article History

Received: 12 June 2023

Accepted: 23 August 2024

First Online: 1 October 2024

Competing interests

: E.H. has an affiliation with Optum. S.R.S. has affiliations with Abbvie/Allergan, Alexion, Amgen, Apellis, ARVO, Astellas, Bayer, Biogen, Boerhinger Ingelheim, Carl Zeiss Meditec, Centervue, Character, Eyepoint, Heidelberg, iCare, IvericBio, Jannsen, Macula Society, Nanoscope, Nidek, NotalVision, Novartis, Optos, OTx, Pfizer, Regeneron, Roche, Samsung Bioepis and Topcon. The other authors declare no competing interests.

Document is current

Any future updates will be listed below